These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18065412)

  • 1. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia.
    Barlow G; Nathwani D; Myers E; Sullivan F; Stevens N; Duffy R; Davey P
    J Antimicrob Chemother; 2008 Feb; 61(2):442-51. PubMed ID: 18065412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Questionnaire survey of guideline implementation for community acquired pneumonia with retrospective analysis of the empiric treatment in 490 patients].
    Xu ZJ; Ding K; Huang H; Sun TY; Ke HX; Tong ZH; Wei TN; Peng K; Yao B; Li FX; Liu JH; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):442-6. PubMed ID: 17673019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of postgraduate education on physician practice for community-acquired pneumonia.
    Ikai H; Morimoto T; Shimbo T; Imanaka Y; Koike K
    J Eval Clin Pract; 2012 Apr; 18(2):389-95. PubMed ID: 21208347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.
    Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP
    J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.
    Capelastegui A; España PP; Quintana JM; Gorordo I; Ortega M; Idoiaga I; Bilbao A
    Clin Infect Dis; 2004 Oct; 39(7):955-63. PubMed ID: 15472846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians.
    Nicks BA; Manthey DE; Fitch MT
    Acad Emerg Med; 2009 Feb; 16(2):184-7. PubMed ID: 19133854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adherence with national guidelines in hospitalized patients with community-acquired pneumonia. Results of CAPO study in Argentina].
    Christensen D; Luna CM; Martínez J; Rodriguez E; Marzoratti L; Gonzalez J; Videla AJ; De Vedia L; Corral J; Benchetrit G; Rodriguez M; Victorio C; Lopardo G; Peyrani P; Ramirez J
    Medicina (B Aires); 2007; 67(6 Pt 2):709-13. PubMed ID: 18422063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
    Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia.
    Serisier DJ; Bowler SD
    Respirology; 2007 May; 12(3):389-93. PubMed ID: 17539843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis.
    Barlow G; Nathwani D; Williams F; Ogston S; Winter J; Jones M; Slane P; Myers E; Sullivan F; Stevens N; Duffey R; Lowden K; Davey P
    Thorax; 2007 Jan; 62(1):67-74. PubMed ID: 16928714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR; Restrepo MI; Mortensen EM; Burgess DS
    Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.
    Mortensen EM; Restrepo M; Anzueto A; Pugh J
    Am J Med; 2004 Nov; 117(10):726-31. PubMed ID: 15541321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.
    Schouten JA; Hulscher ME; Natsch S; Kullberg BJ; van der Meer JW; Grol RP
    Qual Saf Health Care; 2007 Apr; 16(2):143-9. PubMed ID: 17403764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of indicators to evaluate the quality of community-acquired pneumonia management.
    Nathwani D; Williams F; Winter J; Winter J; Ogston S; Davey P
    Clin Infect Dis; 2002 Feb; 34(3):318-23. PubMed ID: 11774078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.
    Blot SI; Rodriguez A; Solé-Violán J; Blanquer J; Almirall J; Rello J;
    Crit Care Med; 2007 Nov; 35(11):2509-14. PubMed ID: 17901833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.